Kyle Gano
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 20SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 34,588140,407 held (−20%) | $132.70 | $4.6M | +2.3% |
| Jan 20SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 1,812140,407 held (−1%) | $132.71 | $240K | +2.3% |
| Nov 4SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 300140,407 held (−0%) | $141.97 | $43K | -4.4% |
- Sell
CEO Kyle Gano sold $4.6M of NBIX at $132.70 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Kyle Gano sold $240K of NBIX at $132.71 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Kyle Gano sold $43K of NBIX at $141.97 — pre-scheduled 10b5-1 plan sale.